Suppr超能文献

用合成卟吩进行光动力疗法对肿瘤微循环的靶向作用

Targeting of the tumor microcirculation by photodynamic therapy with a synthetic porphycene.

作者信息

Abels C, Szeimies R M, Steinbach P, Richert C, Goetz A E

机构信息

Institute for Surgical Research, Klinikum Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany.

出版信息

J Photochem Photobiol B. 1997 Oct;40(3):305-12. doi: 10.1016/s1011-1344(97)00074-2.

Abstract

9-acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn) is a chemically pure substance with fast pharmacokinetics and superior photodynamic properties in vitro as compared to Photofrin. In this study the pharmacokinetics, photodynamic efficacy and tissue localization of ATMPn were investigated in vivo. Amelanotic melanomas (A-Mel-3) were implanted in dorsal skin fold chambers fitted to Syrian Golden hamsters. Fluorescence kinetics of ATMPn (1.4 mumol kg-1 b.w.i.v.; n = 8) were monitored by intravital microscopy. Quantitative measurements of fluorescence intensity were carried out by digital image analysis. For tumor growth studies 1.4 mumol kg-1 was injected 24 h (n = 3), 3 h (n = 3), 1 min (n = 6) and 2.8 mumol kg-1 1 min (n = 6) before PDT (Laser (630 nm) or lamp (600-750 nm), 100 mW cm-2, 100 J cm-2). Tumor volume was measured for 28 d. Solid tumors (n = 3) were excised 1 min after injection of ATMPn (2.8 mumol kg-1) and cryostat sections (20 mm) were analyzed by confocal laser scanning microscopy (CLSM) for tissue localization of the dye. Maximal fluorescence (mean +/- S.E.) arose in the tumor (94 +/- 7%) and surrounding host tissue (67 +/- 5%) 30 s post injection followed by a rapid decrease. Hardly any fluorescence was detectable 12 h after administration. Only PDT 1 min after injection of ATMPn was effective yielding 3/6 complete remissions (2.8 mmol kg-1, laser) and 6/6 complete remissions (2.8 mumol kg-1, lamp), respectively. One minute after injection the dye is primarily localized in the vascular wall of normal and tumor vessels as shown by CLSM. PDT at a time, when the dye is localized primarily in the tumor microcirculation, exhibits the best tumor killing effects showing that vascular targeting is effective in treating solid malignant tumors. ATMPn in liposomes makes administration and light irradiation in one session possible due to its fast pharmacokinetics. Thus, using ATMPn as a photosensitizer may provide more flexibility to perform PDT after surgical exploration and debulking as adjuvant therapy.

摘要

9-乙酰氧基-2,7,12,17-四(β-甲氧基乙基)-卟吩(ATMPn)是一种化学纯物质,与Photofrin相比,其药代动力学较快,体外光动力性能优越。在本研究中,对ATMPn的体内药代动力学、光动力疗效和组织定位进行了研究。将无黑色素黑色素瘤(A-Mel-3)植入适合叙利亚金黄地鼠的背部皮肤褶皱小室中。通过活体显微镜监测ATMPn(1.4 μmol kg⁻¹体重,静脉注射;n = 8)的荧光动力学。通过数字图像分析对荧光强度进行定量测量。对于肿瘤生长研究,在光动力疗法(激光(630 nm)或灯(600 - 750 nm),100 mW cm⁻²,100 J cm⁻²)前24小时(n = 3)、3小时(n = 3)、1分钟(n = 6)注射1.4 μmol kg⁻¹,以及在光动力疗法前1分钟注射2.8 μmol kg⁻¹(n = 6)。测量肿瘤体积28天。在注射ATMPn(2.8 μmol kg⁻¹)1分钟后切除实体瘤(n = 3),并通过共聚焦激光扫描显微镜(CLSM)分析冷冻切片(20 μm)以确定染料的组织定位。注射后30秒,肿瘤(94 ± 7%)和周围宿主组织(67 ± 5%)出现最大荧光(平均值 ± 标准误),随后迅速下降。给药12小时后几乎检测不到任何荧光。仅在注射ATMPn后1分钟进行光动力疗法有效,分别产生3/6完全缓解(2.8 mmol kg⁻¹,激光)和6/6完全缓解(2.8 μmol kg⁻¹,灯)。如CLSM所示,注射后1分钟,染料主要定位于正常和肿瘤血管的血管壁。当染料主要定位于肿瘤微循环时进行光动力疗法,表现出最佳的肿瘤杀伤效果,表明血管靶向在治疗实体恶性肿瘤中有效。由于其快速的药代动力学,脂质体包裹的ATMPn使得一次给药和光照射成为可能。因此,使用ATMPn作为光敏剂在手术探查和减瘤后作为辅助治疗进行光动力疗法可能提供更大的灵活性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验